drug protocol number

SCT21R/008/10

drug sponsor

KAIMRC

drug study

Rivaroxaban

drug trial site

King Abdulaziz Medical City NG (Riyadh), King Abdulaziz Medical City NG (Jeddah),King Khalid University Hospital (Riyadh)

drug status

Ongoing

drug phase